Yaode Wang

Statistics

Publications

Citations

388

H-Index

Active since

2016

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Yaode Wang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in tau-targeted therapy, tau post-translational modifications, and spatial modeling.

ORCID

Publications per year

2016–2024

Publications

Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)

Abbas Walji, Eric D. Hostetler, Harold G. Selnick et al. · Journal of Medicinal Chemistry · 2016 · 180 citations

Life Sciences, Neurobiology, Neuroscience +17

Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies

Harold G. Selnick, J. Fred Hess, Cuyue Tang et al. · Journal of Medicinal Chemistry · 2019 · 136 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Spatial and Temporal Impacts of Socioeconomic and Environmental Factors on Healthcare Resources: A County-Level Bayesian Local Spatiotemporal Regression Modeling Study of Hospital Beds in Southwest China

Chao Song, Yaode Wang, Xiu Yang et al. · International Journal of Environmental Research and Public Health · 2020 · 42 citations · Full text

Computing, Geography, Human Geography +17

A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Tona M. Gilmer, Chun-Hsiang Lai, Kexiao Guo et al. · Molecular Cancer Therapeutics · 2024 · 30 citations · Full text

Medicine, Oncology, Radiation Oncology +16

1–4 of 4